HMGB1 participates in LPS-induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF-κB signaling pathways

被引:118
|
作者
Wang, Jing [1 ]
Li, Ruiting [2 ]
Peng, Zhiyong [1 ]
Hu, Bo [1 ]
Rao, Xin [1 ]
Li, Jianguo [1 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Intens Care Unit, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Wuhan Union Hosp, Tongji Med Coll, Dept Intens Care Unit, Wuhan 430000, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
acute lung injury; high mobility group box 1; polarization of M1 macrophages; absent in melanoma 2 inflammasome; cytokines; MOBILITY GROUP BOX-1; MOUSE MODEL; PROTEIN; HOMEOSTASIS; EXPRESSION; RELEASE; SEPSIS;
D O I
10.3892/ijmm.2019.4402
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
High mobility group box 1 (HMGB1), a crucial proinflammatory cytokine, was reported to activate the absent in melanoma 2 (AIM2) inflammasome, which are both essential in acute lung injury (ALI). However, their interaction mechanism has remained elusive. Macrophages are known to express the AIM2 inflammasome and the main receptors [receptor for advanced glycation end products (RAGE), Toll-like receptor 2/4 (TLR-2/TLR-4)] of HMGB1 to transmit intracellular signals. The present study aimed to indicate whether HMGB1 participates in the process of lipopolysaccharides (LPS)-induced ALI through activating the AIM2 inflammasome in macrophages, as well as inducing polarization of M1 macrophages via TLR2, TLR4 and RAGE/nuclear factor-kappa B (NF-kappa B) signaling pathways. In an in vivo mouse model of LPS-induced ALI, anti-HMGB1, recombinant (r) HMGB1, LPS from Rhodobacter sphaeroides (LPS-RS, TLR2/4 antagonist) or FPS-ZM1 (RAGE antagonist) were administrated. In in vitro studies, bone marrow-derived macrophages from mice primed with LPS were stimulated with or without anti-HMGB1, rHMGB1, LPS-RS, or FPS-ZM1. The findings revealed that anti-HMGB1, LPS-RS and FPS-ZM1 significantly decreased infiltration of inflamematory cells, wet-to-dry ratio, myeloperoxidase activity in the lung, the levels of cytokines, as well as macrophages and neutrophil infiltration in the bronchoalveolar lavage fluid. However, rHMGB1 aggravated the inflammatory response in ALI. Mechanistically, anti-HMGB1, LPS-RS and FPS-ZM1 attenuated activation of TLR2, TLR4, and RAGE/NF-kappa B signaling pathways and expression of the AIM2 inflammasome in macrophages. However, rHMGB1 enhanced their expression levels and induced polarization of M1 macrophages. These results indicated that HMGB1 could participate in the pathogenesis of ALI by activating the AIM2 inflammasome in macrophages, as well as inducing polarization of M1 macrophages through TLR2, TLR4 and RAGE/NF-kappa B signaling pathways.
引用
收藏
页码:61 / 80
页数:20
相关论文
共 50 条
  • [31] Potential regulatory role of the Nrf2/HMGB1/TLR4/NF-κB signaling pathway in lupus nephritis
    Li, Shi-jie
    Ruan, Dan-dan
    Wu, Wei-zhen
    Wu, Min
    Wu, Qiu-yan
    Wang, Han-lu
    Ji, Yuan-yuan
    Zhang, Yan-ping
    Lin, Xin-fu
    Fang, Zhu-ting
    Liao, Li-sheng
    Luo, Jie-wei
    Gao, Mei-zhu
    Wu, Jia-bin
    PEDIATRIC RHEUMATOLOGY, 2023, 21 (01)
  • [32] Potential regulatory role of the Nrf2/HMGB1/TLR4/NF-κB signaling pathway in lupus nephritis
    Shi-jie Li
    Dan-dan Ruan
    Wei-zhen Wu
    Min Wu
    Qiu-yan Wu
    Han-lu Wang
    Yuan-yuan Ji
    Yan-ping Zhang
    Xin-fu Lin
    Zhu-ting Fang
    Li-sheng Liao
    Jie-wei Luo
    Mei-zhu Gao
    Jia-bin Wu
    Pediatric Rheumatology, 21
  • [33] Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-κB pathways in BV2 cells
    Zhang, Jiawei
    Zheng, Yaling
    Luo, Yan
    Du, Yu
    Zhang, Xiaojie
    Fu, Jianliang
    MOLECULAR IMMUNOLOGY, 2019, 116 : 29 - 37
  • [34] Lysophosphatidylcholine Triggers TLR2-and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK Phosphorylation
    Carneiro, Alan Brito
    Ferreira Iaciura, Bruna Maria
    Nohara, Lilian Lie
    Lopes, Carla Duque
    Cordero Veas, Esteban Mauricio
    Mariano, Vania Sammartino
    Bozza, Patricia Torres
    Lopes, Ulisses Gazos
    Atella, Georgia Correa
    Almeida, Igor Correia
    Cardoso Silva-Neto, Mario Alberto
    PLOS ONE, 2013, 8 (09):
  • [35] Calycosin Protects against Focal Cerebral Ischemia/Reperfusion Injury via Inhibiting the HMGB1/TLR4/NF-κB Signaling Pathway
    Wang, Yong
    Wang, Shifeng
    Zhang, Peng
    Xiao, Shengjun
    Shi, Huizhong
    Chen, Zihan
    PHARMACOGNOSY MAGAZINE, 2024, 20 (02) : 606 - 615
  • [36] Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome
    Liu, Yimei
    Liu, Ninghua
    Liu, Yujing
    He, Hongyu
    Luo, Zhe
    Liu, Wenjun
    Song, Nan
    Ju, Minjie
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (03) : 474 - 485
  • [37] Ugonin M, a Helminthostachys zeylanica Constituent, Prevents LPS-Induced Acute Lung Injury through TLR4-Mediated MAPK and NF-κB Signaling Pathways
    Wu, Kun-Chang
    Huang, Shyh-Shyun
    Kuo, Yueh-Hsiung
    Ho, Yu-Ling
    Yang, Chang-Syun
    Chang, Yuan-Shiun
    Huang, Guan-Jhong
    MOLECULES, 2017, 22 (04):
  • [38] Afzelechin alleviates deltamethrin induced hepatic dysfunction via regulating TLR4/MyD88, HMGB1/RAGE and NF-κB pathway
    Alzahrani, Fuad M.
    Alzahrani, Khalid J.
    Alsharif, Khalaf F.
    Hayat, Muhammad Faisal
    Al-Emam, Ahmed
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2025, 497
  • [39] THE ALARMIN EFFECT OF HMGB1/RIP3 ON TRANSFUSION-RELATED ACUTE LUNG INJURY VIA TLR4/NF-ΚB OR MAPK PATHWAY
    Liu, Shuangchun
    Lin, Ronghai
    Zhang, Xianchao
    Lv, Yinyi
    Zhu, Jie
    Chen, Guang
    Du, Yunting
    SHOCK, 2023, 60 (03): : 400 - 409
  • [40] Stigmasterol regulates microglial M1/M2 polarization via the TLR4/NF-κB pathway to alleviate neuropathic pain
    Si, Waimei
    Li, Xin
    Jing, Bei
    Chang, Shiquan
    Zheng, Yachun
    Chen, Zhenni
    Zhao, Guoping
    Zhang, Di
    PHYTOTHERAPY RESEARCH, 2024, 38 (01) : 265 - 279